Utilization of a Multi-modal Comprehensive Genomic and Immune Profiling Testing Strategy Results in a High Rate of Test Success and Detection of Clinically Relevant Biomarkers While Optimizing Tissue Usage
Utilization of a multi-modal CGIP testing strategy resulted in a high rate of test success and detection of clinically relevant biomarkers while optimizing tissue usage.
Authors
- Pratheesh Sathyan
- Kamal S. Saini (ORCID: https://orcid.org/0000-0001-6301-3309)
- Eric A. Severson (ORCID: https://orcid.org/0000-0003-4394-2412)
- Jeffrey M. Conroy (ORCID: https://orcid.org/0000-0003-1764-9706)
- Paul DePietro (ORCID: https://orcid.org/0000-0001-9072-0631)
- Zachary D. Wallen (ORCID: https://orcid.org/0000-0002-2278-7348)
- Marcia Eisenberg
- Shengle Zhang
- Rebecca A. Previs (ORCID: https://orcid.org/0000-0001-8087-9120)
- Brian Caveney
- Mary Nesline (ORCID: https://orcid.org/0000-0003-0523-4597)
- Heidi Ko (ORCID: https://orcid.org/0000-0002-7247-9175)
- Kyle C. Strickland (ORCID: https://orcid.org/0000-0003-1636-5277)
- Shakti Ramkissoon (ORCID: https://orcid.org/0000-0003-3531-2912)
- Alicia Dillard (ORCID: https://orcid.org/0000-0002-8663-376X)
- Durga Prasad Dash (ORCID: https://orcid.org/0000-0002-1090-5191)
- Michelle Green (ORCID: https://orcid.org/0000-0002-6055-4342)
Institutions
- Illumina (United States) (US)
- LabCorp (United States) (US)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Duke Medical Center (US)
- Addenbrooke's Hospital (GB)
- Wake Forest University (US)
Publication Details
- Journal
- Molecular Diagnosis & Therapy
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1007/s40291-025-00793-7
- Citations
- 1
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.94